| Catecholamines, sympathomimetic drugs, and adrenergic receptors antagonists BB Hoffman Goodman and Gilman's the pharmacological basis of therapeutics, 2001 | 1200 | 2001 |
| Fructose-induced insulin resistance and hypertension in rats. IS Hwang, H Ho, BB Hoffman, GM Reaven Hypertension 10 (5), 512-516, 1987 | 1194 | 1987 |
| Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. JH Chin, S Azhar, BB Hoffman The Journal of clinical investigation 89 (1), 10-18, 1992 | 676 | 1992 |
| Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension ALM Swislocki, BB Hoffman, GM Reaven American journal of hypertension 2 (6_Pt_1), 419-423, 1989 | 505 | 1989 |
| Catecholamines and sympathomimetic drugs B Hoffman The pharmacological basis of therapeutics, 166-186, 1990 | 468 | 1990 |
| A role for insulin in the aetiology and course of hypertension? GM Reaven, BB Hoffman The Lancet 330 (8556), 435-437, 1987 | 459 | 1987 |
| Neurotransmission: the autonomic and somatic motor nervous systems BB Hoffman Goodman & Gilman's the pharmacological basis of therapeutics, 105-140, 1996 | 442* | 1996 |
| Radioligand binding studies of adrenergic receptors: new insights into molecular and physiological regulation BB Hoffman, RJ Lefkowitz Annual Review of Pharmacology and Toxicology 20 (1), 581-608, 1980 | 385 | 1980 |
| A selective N-type calcium channel antagonist protects against neuronal loss after global cerebral ischemia. K Valentino, R Newcomb, T Gadbois, T Singh, S Bowersox, S Bitner, ... Proceedings of the National Academy of Sciences 90 (16), 7894-7897, 1993 | 325 | 1993 |
| Alpha-adrenergic receptor subtypes BB Hoffman, RJ Lefkowitz New England Journal of Medicine 302 (25), 1390-1396, 1980 | 321 | 1980 |
| Melmon and Morrelli's clinical pharmacology: basic principles in therapeutics KL Melmon, HF Morrelli (No Title), 1992 | 316 | 1992 |
| Alpha-adrenergic receptor subtypes: quantitative assessment by ligand binding BB Hoffman, A De Lean, CL Wood, DD Schocken, RJ Lefkowitz Life Sciences 24 (19), 1739-1745, 1979 | 310 | 1979 |
| Integrated pharmacology CP Page (No Title), 1997 | 295 | 1997 |
| Decline in beta adrenergic receptor-mediated vascular relaxation with aging in man. HY Pan, BB Hoffman, RA Pershe, TF Blaschke Journal of Pharmacology and Experimental Therapeutics 239 (3), 802-807, 1986 | 259 | 1986 |
| Glucocorticoids induce transcription and expression of the alpha 1B adrenergic receptor gene in DTT1 MF-2 smooth muscle cells. M Sakaue, BB Hoffman The Journal of clinical investigation 88 (2), 385-389, 1991 | 237 | 1991 |
| Adrenergic receptor antagonists BB Hoffman Goodman and Gilman's The pharmacological basis of therapeutics, 221-243, 1990 | 232 | 1990 |
| Heterogeneity of radioligand binding to alpha-adrenergic receptors. Analysis of guanine nucleotide regulation of agonist binding in relation to receptor subtypes BB Hoffman, D Mullikin-Kilpatrick, RJ Lefkowitz The Journal of biological chemistry 255 (10), 4645-4652, 1980 | 222 | 1980 |
| Alpha-1 adrenergic receptors in the nonfailing and failing human heart. MR Bristow, W Minobe, R Rasmussen, RE Hershberger, BB Hoffman Journal of Pharmacology and Experimental Therapeutics 247 (3), 1039-1045, 1988 | 219 | 1988 |
| Quality of care for patients with multiple chronic conditions: the role of comorbidity interrelatedness DM Zulman, SM Asch, SB Martins, EA Kerr, BB Hoffman, MK Goldstein Journal of general internal medicine 29, 529-537, 2014 | 212 | 2014 |
| Vascular reactivity in obstructive sleep apnea syndrome HW Duchna, C Guilleminault, RA Stoohs, JL Faul, H Moreno, BB Hoffman, ... American journal of respiratory and critical care medicine 161 (1), 187-191, 2000 | 202 | 2000 |
